TET2 frameshift and nonsense mutations were frequently identified in AITL (~70%), PTCL-NOS (~60% in TFH cell marker expressing subtype), and CTCL (~10%) [75,96–98]. Here, TET2 is linked to angioimmunoblastic T-cell lymphoma.